Elevated GDF15 levels have been observed in patients with neurodegenerative and cerebrovascular diseases, including AD, PD, and dementia, where plasma concentrations of GDF15 correlate with disease progression and cognitive impairment [1005, 1265, 1275–1277]. Here, GDF15 is linked to cerebrovascular disorder.